As part of a special focus on drug development and clinical research in Africa in February 2023’s DIA Global Forum magazine, Lisa Ursella Collins of Innomas Clinical Research, Leslie Sam from Leslie Sam and Associates, Jayesh Pandit, a Patient Safety Advocate from Kenya, Helen Ndagije of the Uganda National Drug Authority, and Wangui Mathenge from the International Society of Pharmacovigilance’s Africa Chapter outline the work being done to reverse the impact of omitting more than one billion people in Africa from global research h projects.
In 2010, the Deloitte Life Sciences and Healthcare Industry Group collaborated with the Economist Intelligence Unit on a white paper addressing the future of the life sciences industries after the 2008 and 2009 global recession. With feedback from senior executives, C-level executives, and board members, this paper highlighted the growing importance of emerging markets. China, India, Brazil, Russia, Mexico, and Turkey were identified as these emerging markets, but not a single African country.
